TWO SIGMA INVESTMENTS, LP - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$51,000
-93.1%
63,400
-79.5%
0.00%
-100.0%
Q1 2021$742,000
+366.7%
309,212
+474.7%
0.00%
Q4 2020$159,000
+835.3%
53,801
+375.6%
0.00%
Q3 2020$17,000
-80.7%
11,313
-67.9%
0.00%
Q2 2020$88,000
+266.7%
35,200
+200.9%
0.00%
Q1 2020$24,00011,7000.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$19,136,00025.80%
Consonance Capital Management LP 10,540,715$25,298,0002.70%
Wellington Shields & Co., LLC 1,832,769$4,399,0001.58%
Tri Locum Partners LP 1,500,000$3,600,0000.89%
Wellington Shields Capital Management, LLC 2,231,765$5,356,0000.51%
Ghost Tree Capital, LLC 650,000$1,560,0000.37%
1492 Capital Management LLC 159,486$382,0000.11%
Ikarian Capital, LLC 1,268,154$3,044,0000.10%
Sio Capital Management, LLC 203,432$488,0000.10%
Aristides Capital LLC 63,250$152,0000.06%
View complete list of CASI PHARMACEUTICALS INC shareholders